Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 8, Number 10—October 2002

Correction

Correction, Vol. 8, No. 7

Main Article

Table

Prescribing practice changes implemented in response to benchmark data intervention, and mean rate of vancomycin usea before and after intervention, 50 Project ICARE ICUs, January 1996–July 1999b

Vancomycin use prescribing practice change No. of ICUs (%)
(n=50) Vancomycin use before and after practice change
Change absent Change present
Before After Before After p valuec
Hospitalwided 22 (44)
Drug use evaluation 19 (38) 74.2 80.5 105.3 94.1 0.62
Redistributed HICPAC guidelines on VRE  9 (18) 79.4 84.6 116.0 90.6 0.34
Prior approval of vancomycin required 3 (6) 87.2 84.7 67.2 99.4 0.25
Unit-specificd 11 (22)
ICU-specific education on appropriate vancomycin use 9 (18) 75.9 83.3 132.1 96.3 0.01
Removed vancomycin from surgical prophylaxis 3 (6) 82.0 85.9 149.1 82.2 0.01

aDefined daily doses per 1,000 patient-days.
bICARE, Intensive Care Antimicrobial Resistance Epidemiology; ICU, intensive-care units; HICPAC, Healthcare Infection Control Practices Advisory Committee; VRE, vancomycin-resistant enterococci.
cPaired t-test.
dComponents of each major category are not mutually exclusive, so one ICU may be represented in several components of each category.

Main Article

Medline reports the volume should be "8" not "7" in reference "Fridkin, Lawton, Edwards, Tenover, McGowan, Gaynes, et al., 2002".

TOP